Andrew is a second-year MD candidate at Weill Cornell Medicine and a biomedical engineer passionate about shaping the future of healthcare through innovation. He earned his B.S. in Molecular and Cellular Biology from Yale University, concentrating in biotechnology, and his M.S. in Biomedical Engineering from Columbia University, concentrating in design, innovation, and entrepreneurship. At Weill Cornell, Andrew conducts research in the Mosadegh Lab, developing next-generation minimally invasive cardiac devices, and in the Gaudino Lab, advancing surgical outcomes in coronary artery bypass and valvular procedures. He has built multiple ventures, including Future Human, a newsletter spotlighting transformative healthtech startups, and previously co-led the Helix Healthcare Incubator, launching student-led teams in medical devices, AI diagnostics, and digital health. Recognized as a Samvid Scholar Finalist, Andrew is building a career as a physician-innovator—meeting founders, connecting stakeholders, and creating pathways to bring transformative health technologies to patients.
I hope to see a future where heart transplants are no longer necessary, replaced by durable, fully implantable total artificial hearts (TAHs). The technology exists‚ and is improving every year‚ bringing us closer to eliminating waitlist deaths, expanding access to underserved patients, and restoring full mobility. This shift could turn end-stage heart failure into a treatable condition with scalable, long-term mechanical solutions.
ARTIS represents a chance to go from researching and writing about the future of human health on my own time to building it alongside other curious minds. It's an opportunity not only to have my ideas challenged but to constantly learn from colleagues who obsess over the same big questions. I'm excited to collaborate in an environment that pushes us to refine theses, test assumptions, and turn visions into real-world breakthroughs that advance human health.
Launching Future Human during my first year of med school‚ building it from scratch, onboarding two research associates, and putting myself out there fully. I have learned to own outcomes, embrace feedback, and accelerate my leadership growth.